Marta Cremonesi

Measurements of the Higgs boson production and decay rates and constraints on its couplings from a combined ATLAS and CMS analysis of the LHC pp collision data at s = 7 $$ \sqrt{s}=7 $$ and 8 TeV

G. Aad, B. Abbott, J. Abdallah et al. · Journal of High Energy Physics · 2016 · 1.1K citations · Full text

Natural Sciences, Physics, Cosmology +16

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

John J. Zaknun, Lisa Bodei, Jan Mueller‐Brand et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 809 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

Lisa Bodei, Mark Kidd, Giovanni Paganelli et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 466 citations

Medicine, Oncology, Radiation Oncology +7

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors

Lisa Bodei, Marta Cremonesi, Mahila Ferrari et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 424 citations

Medicine, Nephrology, Nuclear Medicine +17

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

Lisa Bodei, Marta Cremonesi, Chiara Maria Grana et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 421 citations

Medicine, Nuclear Medicine, Pharmacology +14